Health Care: Drugs

Cambrex Corp (CBM: NYSE)

$23 n/a | n/a%
12/19/14 - 04:06 PM ET
Company Profile
Price and Volume
Recent Price 23.00
52 Week High 24.45
52 Week Low 15.20
Avg. Daily Vol. (Mil) 0.28
Beta (3 year) 1.06
Share Related Items
Mkt Cap (Mil) 712.90
Shares Out (Mil) 31.00
Float (Mil) 26.76
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 2.20
LT Debt/ Equity 0.26
Total Debt / Equity 0.26
Valuation Ratios
Price Earnings 19.00
Price/Sales 2.03
Price/Book 3.07
Price/Cash Flow 11.50
Per Share Data
Earnings 1.21
Sales 11.31
Book Value 7.50
Cash Flow 2.00
Business Summary
Cambrex Corp is a life sciences company that provides products and services to accelerate and improve the development and commercialization of new and generic therapeutics.
General Information
One Meadowlands Plaza
East Rutherford, NJ 07073
www.cambrex.com
Industry : Drugs
Sector: Health Care
Employees: 936
CEO: Steven M. Klosk
Short Interest
Current Month (Mil) 0.57
Previous Month (Mil) 0.61
Short Interest Ratio (Days) 2.00
Management Effectiveness
Return on Equity 16.50
Return on Assets 8.60
Return on Investments 13.10
Profitability
Gross Margin 39.50
EBIT Margin 11.30
Profit Margin 10.90

Portfolios with CBM

Latest CBM Headlines from TheStreet

More Financial News for CBM

Press Releases for CBM

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter